news&events

Nov
22

Antios Therapeutics Announces Agreement with IRBM, INGM and OSR to Acquire Fourth-Generation HBV Capsid Assembly Modulators (CAMs)

On November 15, 2021 – Antios Therapeutics, Inc. (“Antios”), a clinical-stage biopharmaceutical company developing innovative therapies to treat and cure chronic hepatitis B virus (HBV), announced the agreement to purchase the IP rights to a novel series of fourth-generation capsid assembly modulators (CAMs) discovered and developed jointly by IRBM, Promidis/CNCCS (a subsidiary of IRBM), Istituto [...]
By Donatella Balconi | news&events . Senza categoria
DETAIL
Jul
27

New breakthrough to help immune systems in the fight against cancer

New research has identified potential treatment that could improve the human immune system’s ability to search out and destroy cancer cells within the body. Scientists have identified a way to restrict the activity a group of cells which regulate the immune system, which in turn can unleash other immune cells to attack tumours in cancer [...]
DETAIL
May
11

Merck ‘Grant for Oncology Innovation’ awards recognize recipients for pushing boundaries in oncology research

Merck today announced recipients of the fourth annual Grant for Oncology Innovation (GOI) awards. The three winners of this prestigious program were awarded €1 million in total to progress their research. Recipients of the 2017 GOI award are: Renata Maria Grifantini, National Institute of Molecular Genetics, Milan, Italy, for her proposal: “Novel targets of tumor-infiltrating CD4+ regulatory [...]
By Sabrina | home_en . news&events
DETAIL
Mar
04

EMBL recognises the work of Raffaele De Francesco with the Lennart Philipson Award

The European Molecular Biology Laboratory (EMBL) has assigned the 2018 Lennart Philipson Award to Raffaele De Francesco, an EMBL alumnus now head of the Virology Laboratory of INGM. Raffaele De Francesco’s work on the Hepatitis C virus (HCV) led to a medical revolution. Previously, certain chronic viral infections had been kept under control using drugs, [...]
By Raffele De Francesco | home_en . news&events
DETAIL
Dec
21

INGM among the partners of CurB: a project funded by Region Lombardy to fight chronic HBV

Luca del Gobbo, delegate for University, research and Open innovation at the Lombardy Region, signed the research agreement with Promidis srl to develop innovative drugs to fight and win the hepatitis B virus. Partners in the project are Istituto Nazionale di Genetica Molecolare-INGM, San Raffaele hospital, Univerity of Milano and Policlicnico “San Matteo” in Pavia. [...]
By Raffele De Francesco | home_en . news&events
DETAIL
May
23

Forgeries as obstacles to change and innovation

INGM is proud to have been the host of the first "Salotto Invernizzi - INGM", on the topic "Forgeries as obstacles to change and innovation". Among others, Minister of Health Beatrice Lorenzin spoke. The discussion was moderated by Paolo Mieli. Click here to download the poster of the event. A few moments can were recorded [...]
By INGM | home_en . news&events
DETAIL
Apr
06

Frontiers in Molecular Biology: From Single Cells to 3D-cell culture

14-16 giugno 2017 Salone Pio XII di Palazzo Schuster, Via S. Antonio, 5 – Milano Massimiliano Pagani e Raffaele De Francesco di INGM assieme a Marco Bianchi (San Raffaele), saranno gli ospiti del Meeting Annuale 2017 della Società Italiana di Biofisica e Biologia Molecolare, che avrà come tema “From Single Cells to 3D-Cell Culture”. Il [...]
By INGM | home_en . news&events
DETAIL
Feb
24

UniStem Day 2017

UnistemDay 2017 at INGM. The long and fascinating journey of stem cells research On March 17th, for the ninth year Italy and Europe will join to this collective event to talk about science and stem cells. A whole day dedicated to the science of stem cells. Talks, seminars and events open to the public and [...]
By INGM | home_en . news&events
DETAIL
Top